Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study
Objective: To evaluate the risk of venous thromboembolism (VTE) with tofacitinib compared with TNFis in patients with RA. Methods: RA patients initiating tofacitinib or a TNFi without use of any biologic or tofacitinib any time prior were identified from IBM 'MarketScan' (2012-18), Medicar...
Main Authors: | Desai, R.J (Author), Khosrow-Khavar, F. (Author), Kim, S.C (Author), Pawar, A. (Author), Weinblatt, M.E (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis
by: Sandra Pérez-Baos, et al.
Published: (2019-01-01) -
Tofacitinib is a modern solution to the problem of resistant rheumatoid arthritis
by: I. V. Menshikova, et al.
Published: (2019-05-01) -
Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives
by: Ly K, et al.
Published: (2019-08-01) -
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future
by: Jacopo Angelini, et al.
Published: (2020-07-01) -
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
by: Peter Nash, et al.
Published: (2018-11-01)